Hepatitis C virus induces MDSCs-like monocytes through TLR2/PI3K/AKT/STAT3 signaling

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Zhai, Naicui ^a   Li, Haijun ^a   Song, Hongxiao ^a   Yang, Yang ^a   Cui, An ^a   Li, Tianyang ^a   Niu, Junqi ^a   Crispe, Ian Nicholas ^a,b   Su, Lishan ^a,c   Tu, Zhengkun ^a  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CORE PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN KINASE B; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; STAT3 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION CONTROL; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; VIRION; WESTERN BLOTTING; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; GENE EXPRESSION PROFILING; HEPACIVIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONOCYTE; PHYSIOLOGY;

CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION PROFILING; HEPACIVIRUS; HUMANS; LYMPHOCYTE ACTIVATION; MONOCYTES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 2;

EID: 85010411056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0170516     Document Type: Article

References (50)

1. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepa tocellular carcinoma. Nat Rev Cancer 2013;13:123-135. DOI: 10.1038/nrc3449 PMID: 23344543
2. Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol 2010;10:514-526. DOI: 10.1038/nri2802 PMID: 20577268
3. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005;436:946-952. DOI: 10.1038/nature04079 PMID: 16107834
4. Pawlotsky JM. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 2014;146:1176-1192. DOI: 10.1053/j.gastro.2014.03.003 PMID: 24631495
5. Ding Q, Cao X, Lu J, Huang B, Liu YJ, Kato N, et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J Hepatol 2013;59:52-58. DOI: 10.1016/j.jhep. 2013. 03.019 PMID: 23542348
6. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, et al. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 2007;133:1627-1636. DOI: 10.1053/j.gastro.2007.08.003 PMID: 17916356
7. Tu Z, Pierce RH, Kurtis J, Kuroki Y, Crispe IN, Orloff MS. Hepatitis C Virus Core Protein Subverts the Antiviral Activities of Human Kupffer Cells. Gastroenterology 2010;138:305-314. DOI: 10.1053/j.gastro. 2009.09.009 PMID: 19769973
8. Hosomura N, Kono H, Tsuchiya M, Ishii K, Ogiku M, Matsuda M, et al. HCV-related proteins activate Kupffer cells isolated from human liver tissues. Dig Dis Sci 2011;56:1057-1064. DOI: 10.1007/s10620-010-1395-y PMID: 20848204
9. Zhai N, Chi X, Li T, Song H, Li H, Jin X, et al. Hepatitis C virus core protein triggers expansion and activation of CD4+CD25+ regulatory T cells in chronic hepatitis C patients. Cell Mol Immunol 2015;12:743-749. DOI: 10.1038/cmi.2014.119 PMID: 25531392
10. Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol 2012;24:97-106. DOI: 10.1093/intimm/dxr104 PMID: 22190574
11. Waggoner SN, Cruise MW, Kassel R, Hahn YS. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol 2005;175:4706-4714. PMID: 16177118
12. Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, et al. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 2006;80:9226-9235. DOI: 10. 1128/JVI.00459-06 PMID: 16940534
13. Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn YS. Extracellular Hepatitis C Virus Core Protein Activates STAT3 in Human Monocytes/Macrophages/Dendritic Cells via an IL-6 Autocrine Pathway. J Biol Chem 2011;286:10847-10855. DOI: 10.1074/jbc. M110.217653 PMID: 21282107
14. Ifrim DC, Quintin J, Joosten LA, Jacobs C, Jansen T, Jacobs L, etal. Trained Immunity or Tolerance: Opposing Functional Programs Induced in Human Monocytes after Engagement of Various Pattern Recognition Receptors. Clin Vaccine Immunol 2014;21:534-545. DOI: 10.1128/CVI.00688-13 PMID: 24521784
15. Nagaraj S, Nelson A, Youn JI, Cheng P, Quiceno D, Gabrilovich DI. Antigen-specific CD4 (+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res 2012;72:928-938. DOI: 10.1158/0008-5472. CAN-11-2863 PMID: 22237629
16. Wu J, Zhang R, Tang N, Gong Z, Zhou J, Chen Y, etal. Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity. J Leukoc Biol 2015;97:191-200. DOI: 10.1189/jlb.5A1113-626RR PMID: 25341727
17. Mielcarek M, Martin PJ, Torok-Storb B. Suppression of Alloantigen-Induced T-Cell Proliferation by CD14+ Cells Derived From Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells. Blood 1997;89:1629-1634. PMID: 9057645
18. Ino K, Bierman PJ, Varney ML, Heimann DG, Kuszynski CA, Walker SA, et al. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation. Cancer Immunol Immunother 1996;43:206-212. PMID: 9003465
19. Jitschin R, Braun M, Buttner M, Dettmer-Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 2014;124:750-760. DOI: 10.1182/blood-2013-12-546416 PMID: 24850760
20. Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, et al. Upregulation of indoleamine 2, 3-dioxygenase in hepatitis C virus infection. J Virol 2007;81:3662-3666. DOI: 10.1128/JVI. 02248-06 PMID: 17229698
21. Higashitani K, Kanto T, Kuroda S, Yoshio S, Matsubara T, Kakita N, et al. Association of enhanced activity of indoleamine 2, 3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection. J Gastroenterol 2013;48:660-670. DOI: 10.1007/s00535-012-0667-z PMID: 22976933
22. Schulz S, Landi A, Garg R, Wilson JA, van Drunen Littel-van den Hurk S. Indolamine 2, 3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients. Clin Exp Immunol 2015;180:484-498. DOI: 10.1111/cei.12586 PMID: 25605587
23. Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, et al. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012;55:343-353. DOI: 10.1002/hep. 24700 PMID: 21953144
24. Zeng QL, Yang B, Sun HQ, Feng GH, Jin L, Zou ZS, et al. Myeloid-Derived Suppressor Cells Are Associated with Viral Persistence and Downregulation of TCR £ Chain Expression on CD8 (+) T Cells in Chronic Hepatitis C Patients. Mol Cells 2014;37:66-73. DOI: 10.14348/molcells.2014.2282 PMID: 24552712
25. Pang X, Song H, Zhang Q, Tu Z, Niu J. Hepatitis C virus regulates the production of monocytic myeloidderived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling. Clin Immunol 2016;164:57-64. PMID: 26821305
26. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005;102:9294-9299. DOI: 10.1073/pnas.0503596102 PMID: 15939869
27. Shi L, Chen S, Yang L, Li Y. The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies. J Hematol Oncol 2013;6:74. DOI: 10.1186/1756-8722-6-74 PMID: 24283718
28. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009;206:3015-3029. DOI: 10.1084/jem.20090847 PMID: 20008522
29. Shi F, Shi M, Zeng Z, Qi RZ, Liu ZW, Zhang JY, et al. PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer 2011;128:887-896. DOI: 10.1002/ijc.25397 PMID: 20473887
30. Brusa D, Serra S, Coscia M, Rossi D, D'Arena G, Laurenti L, et al. The PD-1/PD-L1 Axis Contributes To T-Cell Dysfunction In Chronic Lymphocytic Leukemia. Haematologica 2013;98:953-963. DOI: 10.3324/haematol.2012.077537 PMID: 23300177
31. Yasui H, Takai K, Yoshida R, Hayaishi O. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2, 3-dioxygenase: its possible occurrence in cancer patients. Proc Natl Acad Sci U S A 1986;83:6622-6626. PMID: 2428037
32. Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, et al. Tryptophan catabolism and T cell responses. Adv Exp Med Biol 2003;527:27-35. PMID: 15206713
33. Munn DH, Mellor AL. Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007;117:1147-1154. DOI: 10.1172/JCI31178 PMID: 17476344
34. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, et al. Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients. J Virol 2001;75:8240-8250. DOI: 10.1128/JVI.75.17.8240-8250.2001 PMID: 11483769
35. Masalova OV, Atanadze SN, Samokhvalov EI, Petrakova NV, Kalinina TI, Smirnov VD, et al. Detection of hepatitis C virus core protein circulating within different virus particle populations. J Med Virol 1998;55:1-6. PMID: 9580878
36. Sundstrom S, Ota S, Dimberg LY, Masucci MG, Bergqvist A. Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses. J Virol 2005;79:2230-2239. DOI: 10.1128/JVI.79.4.2230-2239.2005 PMID: 15681425
37. Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation. J Biol Chem 2004;279:43479-43486. DOI: 10.1074/jbc. M407640200 PMID: 15292184
38. Soguero C, Joo M, Chianese-Bullock KA, Nguyen DT, Tung K, Hahn YS. Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model. J Virol 2002;76:9345-9354. DOI: 10.1128/JVI.76.18.9345-9354.2002 PMID: 12186917
39. Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2, 3-dioxygenase in plasmacytoid dendritic cells. Blood 2007;109:3351-3359. DOI: 10.1182/blood-2006-07-034785 PMID: 17158233
40. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2, 3-dioxygenase. Nat Med 2003;9:1269-1274. DOI: 10.1038/nm934 PMID: 14502282
41. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, et al. Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2, 3-Dioxygenase. Science 2002;297:1867-1870. DOI: 10.1126/science.1073514 PMID: 12228717
42. Jurgens B, Hainz U, Fuchs D, Felzmann T, Heitger A. Interferon-gamma-triggered indoleamine 2, 3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood 2009;114:3235-3243. DOI: 10.1182/blood-2008-12-195073 PMID: 19625705
43. Kortylewski M, Yu H. Role of Stat3 in suppressing anti-tumor immunity. Curr Opin Immunol 2008;20:228-233. DOI: 10.1016/j.coi.2008.03.010 PMID: 18479894
44. Mounayar M, Kefaloyianni E, Smith B, Solhjou Z, Maarouf OH, Azzi J, et al. PI3ka and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization. Stem Cells 2015;33:1892-1901. DOI: 10.1002/stem.1986 PMID: 25753288
45. Zheng J, Liang H, Xu C, Xu Q, Zhang T, Shen T, et al. An unbalanced PD-L1/CD86 ratio in CD14 (++) CD16 (+) monocytes is correlated with HCV viremia during chronic HCV infection. Cell Mol Immunol 2014;11:294-304. DOI: 10.1038/cmi.2013.70 PMID: 24531620
46. Jeong HY, Lee YJ, Seo SK, Lee SW, Park SJ, Lee JN, et al. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J Leukoc Biol 2008;83:755-764. DOI: 10.1189/jlb.0307168 PMID: 18086898
47. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2, 3-Dioxygenase. J Exp Med 2002;196:459-468. DOI: 10.1084/jem.20020121 PMID: 12186838
48. Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer 2013;13:739-752. DOI: 10.1038/nrc3581 PMID: 24060865
49. Vasquez-Dunddel D, Pan F, Zeng Q, Gorbounov M, Albesiano E, Fu J, et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J Clin Invest 2013;123:1580-1589. DOI: 10.1172/JCI60083 PMID: 23454751
50. Liu Y, She LH, Wang XY, Zhang GL, Yan Y, Lin CS, et al. Expansion of myeloid-derived suppressor cells from peripheral blood decreases after 4-week antiviral treatment in patients with chronic hepatitis C. Int J Clin Exp Med 2014;7:998-1004. PMID: 24955173